| Literature DB >> 26140219 |
Amir-Alexander Ghoniem1, Yahya Açil1, Jörg Wiltfang1, Matthias Gierloff1.
Abstract
To date there is no sufficient in vitro fat tissue engineering and a protocol has not been well established for this purpose. Therefore, we evaluated the in vitro influence of two different adipogenic growth media for their stimulation potential on different cell lineages to clearly define the most potent adipogenic growth media for future in vitro tissue engineering approaches. The samples for differentiation were composed of human adipogenic-derived stroma cells (hADSCs) and human bone marrow mesenchymal stroma cells (hMSCs). A normal adipogenic medium (NAM) and a specific adipogenic medium (SAM) were tested for their adipogenic stimulation potential. After 10 days and 21 days the relative gene expression was measured for the adipogenic marker genes PPARγ2, C/EBPα, FABP4, LPL, and GLUT4 detected through real time reverse transcriptase polymease chain reaction (RT-PCR). Other study variables were the comparison between NAM and SAM and between the used cells hADSCs and hMSCs. Additionally an Oil-Red staining was performed after 21 days. Our results revealed that only SAM was significantly (P<0.05) superior in the differentiation process in contrast to NAM for 10 days and 21 days. As well was SAM superior to differentiate the used cell lineages. This was evaluated by the detected marker genes PPARγ2, C/EBPα, FABP4, LPL, and GLUT4 through real time RT-PCR and by Oil-Red staining. In addition, the hMSCs proofed to be equal donor cells for adipogenic differentiation especially when stimulated by SAM. The results suggest that the SAM should be established as a new standard medium for a more promising in vitro adipogenic differentiation.Entities:
Keywords: Adipogenic differentiation; C/EBPα; Fat tissue engineering; PPARγ2; Real time RT-PCR
Year: 2015 PMID: 26140219 PMCID: PMC4488646 DOI: 10.5115/acb.2015.48.2.85
Source DB: PubMed Journal: Anat Cell Biol ISSN: 2093-3665
Material and methods: cell culture media used for adipogenic stimulation
| Medium | Basal medium | Supplementation | Manufacturer |
|---|---|---|---|
| Culture medium (CM) | DMEM-LG | Basal supplementation | All from Biochrom AG, Berlin, Germany |
| - Fetal calf serum 10% | |||
| - 100 IU/ml penicillin | |||
| - 100 µg/ml streptomycin | |||
| - 2 mM L-glutamine | |||
| - 1 mM ascorbat-2-phosphate | |||
| Normal adipogenic medium | CM | Normal adipogenic supplementation | All from Sigma-Aldrich Chemie GmbH, Steinheim, Germany |
| - 500 nM dexamethasone | |||
| - 500 µM isobutyl-methylxanthine | |||
| - 50 µM indomethacin | |||
| - 0.1 UI/ml insulin | |||
| Specific adipogenic medium | DMEM/Ham's F-12 with L-glutamine | Basal supplementation | All from Biochrom AG, Berlin, Germany |
| - 10% fetal calf serum | |||
| - 100 IU/ml penicillin | |||
| - 100 µg/ml streptomycin | |||
| - 2 mM L-glutamine | |||
| - 1 mM ascorbat-2-phosphate | |||
| Specific adipogenic supplementation | All from Sigma-Aldrich Chemie GmbH, Steinheim, Germany | ||
| - 2 nM triiodothyronine | |||
| - 10 nM hydrocortisone | |||
| - 500 µM isobutyl-methylxanthine | |||
| - 500 µM dexamethasone | |||
| - 1 µM rosiglitazone | |||
| - 0.15 UI/ml insulin |
DMEM-LG, Dulbecco's modified Eagle's medium low glucose.
Material and methods: primer used for adipogenic stimulation
| Primer (official name) | Primer (official symbol) | Entrez gene ID | Size (bp) | Cat. No. (Qiagen) |
|---|---|---|---|---|
| CCAAT/enhancer binding protein (C/EBP), alpha | CEBPA | 1050 | 2,591 | QT00203357 |
| Peroxisome proliferator-activated receptor gamma | PPARG | 5468 | 1,818 | QT00029841 |
| Fatty acid binding protein 4, adipocyte | FABP4 | 2167 | 838 | QT00055517 |
| Lipoprotein lipase | LPL | 4023 | 3,747 | QT00036771 |
| Solute carrier family 2 (facilitated glucose transporter), member 4 | SLC2A4 | 6517 | 3,159 | QT00097902 |
Fig. 1Oil-Red staining after 21 days (×20). Staining after 10 days not shown. hADSC, human adipogenic-derived stroma cell; hMSC, human bone marrow mesenchymal stroma cell; CM, culture medium; NAM, normal adipogenic medium; SAM, specific adipogenic medium. Scale bars=50 µm.
Descriptive statistics: percentage values of Oil-Red O quantitation
| Cell population | Cell culture media | No. | Mean (%) | Median (%) | SD (%) | SEM (%) | Minimum value (%) | Maximum value (%) | 95% CI |
|---|---|---|---|---|---|---|---|---|---|
| hADSCs | NAM t2 | 8 | 32.14 | 28.57 | 11.32 | 1.68 | 27.27 | 41.38 | 24.30-39.98 |
| SAM t2 | 8 | 81.17 | 80.28 | 68.48 | 9.98 | 53.33 | 84.47 | 33.72-128.62 | |
| hMSCs | NAM t2 | 8 | 18.39 | 19.29 | 12.30 | 2.15 | 12.50 | 22.22 | 9.87-26.91 |
| SAM t2 | 8 | 76.73 | 79.36 | 50.76 | 9.17 | 75.00 | 75.93 | 41.56-111.90 |
SD, standard error; SEM, standard error of mean; CI, confidence interval; hADSC, human adipogenic-derived stroma cell; hMSC, human bone marrow mesenchymal stroma cell; NAM, normal adipogenic medium; SAM, specific adipogenic medium.
Evaluation of the statistical analysis results of real time RT-PCR
| Cell lineage | Medium | |||||
|---|---|---|---|---|---|---|
| PPARγ2 | C/EBPα | FABP4 | LPL | GLUT4 | ||
| hADSCs | NAM t1 | <0.05 | <0.01 | <0.05 | <0.001 | <0.001 |
| SAM t1 | ||||||
| NAM t2 | ns | ns | <0.05 | <0.01 | ns | |
| SAM t2 | ||||||
| hMSCs | NAM t1 | ns | ns | ns | ns | <0.05 |
| SAM t1 | ||||||
| NAM t2 | <0.001 | <0.001 | <0.01 | <0.001 | ns | |
| SAM t2 | ||||||
Comparison of SAM vs. NAM (n=3, independent t test). Only SAM showed significant differences over NAM. NAM compared to SAM was not significant (data not shown). P<0.05, significant; P<0.01, highly significant; P<0.001, highly significant. RT-PCR, reverse transcriptase polymerase chain reaction; hADSC, human adipogenic-derived stroma cell; hMSC, human bone marrow mesenchymal stroma cell; NAM, normal adipogenic medium; SAM, specific adipogenic medium; ns, not significant.
Fig. 2Comparision of relative gene expression levels between NAM and SAM after 10 and 21 days. The comparison between the NAM and the SAM is portrayed per tissue (hADSCs or hMSCs). Relative gene marker expression (mean±standard deviation; n=3; independent t test: P<0.05) obtained from the real time reverse transcriptase polymerase chain reaction. Only significant differences between SAM over NAM where detectable and are shown as P-value above the graphs. hADSC, human adipogenic-derived stroma cell; hMSC, human bone marrow mesenchymal stroma cell; NAM, normal adipogenic medium; SAM, specific adipogenic medium.
Fig. 3Flowchart shows the allocation of adipogenic growth media (SAM and NAM) with each cell type (hADSC and hMSC). Arrows show up- and downregulation of the relative gene expression level. To get a further insight of relative expression level ratios please refer to Fig. 1. Significant differences where only detectable for SAM towards NAM. For further statistic exploration please refer to Table 4. hADSC, human adipogenic-derived stroma cell; hMSC, human bone marrow mesenchymal stroma cell; NAM, normal adipogenic medium; SAM, specific adipogenic medium.